Three-week versus four-week schedule of cisplatin and gemcitabine: results of a randomized phase II study.
Soto Parra, H.; Cavina, R.; Latteri, F.; Sala, A.; Dambrosio, M.; Antonelli, G.; Morenghi, E.; Alloisio, M.; Ravasi, G.; Santoro, A.; Annals of Oncology, 2002, vol. 13, issue 7, p 1080, ISSN 09237534. ISBN 09237534.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef